Efficacy of SCH56592 in a rabbit model of invasive aspergillosis (Q33979027)

30 July 2017

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis (English)

1 reference

30 July 2017

0 references

invasive aspergillosis

1 reference

W R Kirkpatrick

1

1 reference

30 July 2017

R K McAtee

2

1 reference

30 July 2017

A W Fothergill

3

1 reference

30 July 2017

D Loebenberg

4

1 reference

30 July 2017

M G Rinaldi

5

1 reference

30 July 2017

T F Patterson

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

1 reference

30 July 2017

44

1 reference

30 July 2017

3

1 reference

30 July 2017

780-782

1 reference

Aspergillus fumigatus and aspergillosis

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

SCH56592 treatment of murine invasive aspergillosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89767

Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191

5 July 2018

1 reference

12 December 2020

Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model

1 reference

12 December 2020

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

1 reference

12 December 2020

New antifungal agents

1 reference

12 December 2020

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen

1 reference

12 December 2020

10.1128/AAC.44.3.780-782.2000

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference